Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma and breast cancer immunotherapy at Nordwest Clinic.
Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads immunotherapy research and treatment.
Prof. Köstler specializes in breast cancer immunotherapy, combining over 22 years of experience of clinical experience with cutting-edge research at Wiener Privatklinik.
Dr. Amir specializes in immunotherapy for breast cancer, including targeted therapy with Keytruda (Pembrolizumab). His work includes over 30 presentations at scientific meetings.
Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings a focused approach to immunotherapy at Istinye Liv University Hospital.
Dr. Séverine Iborra leads the gynecology department at Städtisches Klinikum Solingen, with a focus on oncological diagnostics and breast cancer treatment.
Specializes in immunotherapy for breast cancer with a focus on molecular diagnostics and targeted therapies at Medical Center in Solingen.
Professor Cemil Bilir specializes in medical oncology with international training at Cleveland Clinic and Northeastern University.
Dr. Alemdar specializes in medical oncology with a focus on breast cancer immunotherapy at Medical Park Antalya Hospital Complex.
Dr. Ercan Ozden specializes in immunotherapy for breast cancer at VM Medical Park Pendik Hospital, with extensive training in medical oncology.
Expert in oncoplastic breast surgery and ROLL/SLNB techniques – Dr. Zengel brings precision to breast cancer care at Medicalpoint International Hospital.
Professor of Medical Oncology at Trakya University, specializing in breast cancer immunotherapy for over 29 years of experience.
Associate Professor Nail Paksoy is a medical oncologist specializing in breast cancer immunotherapy at Medipol Bahçelievler Hospital, with extensive involvement in international clinical trials.
Assoc. Prof. Atakan Topcu, M.D. specializes in targeted therapies and immunotherapy for breast cancer at Medipol Acibadem District Hospital.
Prof. Atci specializes in medical oncology with focused research on immunotherapy for breast cancer at Liv Hospital Topkapı.
Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.
Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).
Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).
Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.
He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.
Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.
She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.
Assoc. Prof. Ayse Irem Yasin specializes in immunotherapy for breast cancer at Medipol Acibadem District Hospital, with training from top institutions worldwide.
Leading researcher in breast cancer subtypes – Dr. Prat focuses on translating lab findings into personalized immunotherapy approaches at Hospital Quiron Barcelona.